Considering that treatment with demethylating agents can restore gene expression and inactivate hOGG1 [39], the use of such agents may be the ideal way to reduce the risk of developing NSCLC among individuals with hOGG1 hypermethylation. Here, OGG1 is linked to non-small cell lung carcinoma.